AzTrials
AzTrials

StrokeSPART-ANCT06948721

Study of the Participation of People With Aphasia Post Stroke and Their Caregivers in Valladolid Region (Spain)

An observational study of Stroke and Aphasia, run by Centro Integral de Rehabilitación.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to determine the level of community participation of people with post-stroke aphasia and their caregivers, as well as the factors that facilitate or interfere with this participation in the Valladolid region (Spain). The main questions that this study aims to answer are: 1. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Aphasia
How many people
50 participants
Where
No sites listed yet
Study dates
6 May 2025to 20 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The participants in the study (people with aphasia and their caregivers) will be drawn from the registry of people treated at the companies CIRONBRAIN and CIRONLAB, which comprise the research team. Sample recruitment will also be conducted through CIRONBRAIN's social media channels, and through requests for collaboration with local disability organizations and healthcare professionals in the Valladolid region who are familiar with the project and who may be eligible for selection.

Who may be able to join

  • Chronic Stroke (stroke onset above six months).
  • Aphasia post stroke.
  • Residents in Valladolid Region.
  • Age over 18 years.
  • Ability to walk equal to or greater than 3 according to the Functional Ambulation Category (FAC).
  • Informed consent acceptance.

Who cannot join

  • Stroke onset below of Six months
  • Age under 18 years
  • Both in the case of the person with aphasia and their caregiver, presence of other pathologies that affect functional independence

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Jorge Alegre-Ayala, Ph.D OTR contact

+34680274889

jalegreayala@cironrehabilitacion.es

About this study

The objective of this study is to determine the level of community participation of people with post-stroke aphasia and their caregivers, as well as the factors that facilitate or interfere with this participation in the Valladolid region (Spain).

The main questions that this study aims to answer are:

  1. What is the retained activities of the people with aphasia post-stroke?
  2. What is the retained activities of the caregivers of people with aphasia post-stroke?
  3. What factors influence the community participation of people with aphasia post-stroke and their caregivers?
Conditions
Stroke, Aphasia
Keywords
Aphasia post stroke, caregiver, community participation, occupational therapy, Speech Language Therapy
Medical subject headings
Stroke, Aphasia, Communication Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06948721
Study groupRoleWhat they receive
people with aphasia post strokeNot described
Caregivers of people with aphasia post strokeNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Activity Card Sort

    The Activity Card Sort will determine the level of participation maintained by people with aphasia and their caregivers at the time of the assessment. It will provide data on overall participation, as well as participation in leisure, social, educational, and work activities. The Activity Card Sort scale scores range from 0 to 100%. Higher percentages, better.

    Measured: Baseline

Secondary outcomes (6)
  1. The Western Aphasia Battery (WAB)

    The Western Aphasia Battery (WAB) is a tool used to assess the linguistic skills (information content, fluency, auditory comprehension, repetition, naming and word finding, reading, and writing) and nonlinguistic skills (drawing, block design, calculation, and praxis) of adults with aphasia. This provides information for the diagnosis of the type of aphasia. The Western Aphasia Battery uses an Aphasia Quotient (AQ) to assess the severity of aphasia, with scores ranging from 0 to 100. Higher score, less severity of aphasia.

    Measured: Baseline

  2. Barthel Index (BI)

    The BI assesses the level of functional independence in basic activities of daily living (eating, hygiene, dressing, mobility, etc.). Barthel index scores range from 0 to 100 points. Higher scores, better.

    Measured: Baseline

  3. Zarit Caregiver Burden Interview (ZBI)

    The aim of the Zarit Caregiver Burden Interview (ZBI) is to assess the perceived burden experienced by caregivers, particularly in terms of the physical, emotional, social, and financial impacts of caregiving. The Zarit Caregiver Burden Interview scale scores range from 22 to 110 points. Higher scores indicate worse outcomes.

    Measured: Baseline

  4. Six-Minute Walk Test (6MWT)

    The Six-Minute Walk test aims to assess a person's functional exercise capacity by measuring the distance they can walk in six minutes on a flat surface. Higher score, better.

    Measured: Baseline

  5. Ten-Meter Walk Test (10MWT)

    The Ten-Meter Walk Test evaluates walking speed over a short distance (10 meters). This scale provides data on normal speed and fast speed. Higher speed, better.

    Measured: Baseline.

  6. Hospital Anxiety and Depression Scale

    The purpose of the Hospital Anxiety and Depression Scale is identify depression and anxiety among physically ill patients, through a brief questionnaire which involves both dimensions. The scoring of the Hospital Anxiety and Depression Scale 0-21 for each subscale, with higher scores indicating greater anxiety or depression.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2025
  2. Study start6 May 2025 (estimated)
  3. Primary completion28 Feb 2026 (estimated)
  4. Study completion20 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06948721
Sponsor's protocol ID
CIRON
Acronym
SPART-A
Status last verified
Apr 2025
First submitted
11 Apr 2025
Last updated
2 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Aphasia, run by Centro Integral de Rehabilitación.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 May 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jorge Alegre-Ayala, Ph.D OTR (+34680274889, jalegreayala@cironrehabilitacion.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Activity Card Sort (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in